Data support potential of isaralgagene civaparvovec as a one-time, well tolerated and durable Fabry disease gene therapy to provide meaningful, multi-organ clinical benefits that could fundamentally s ...

Johns Hopkins scientists and partners across the country are conducting research that could dramatically improve transplants, from technology that preserves donor tissue longer to treatments that redu ...

Assisted reproductive technologies (ART) have become an integral component of infertility care worldwide. Alongside their widespread clinical use, growing ...

The FDA Center for Drug Evaluation and Research has accepted a letter of intent for the first biomarker for idiopathic pulmonary fibrosis into its Biomarker Qualification Program, according to a press ...

Sexual dysfunction is a reality for many women, but the subject remains taboo. A large percentage of women remain untreated, a problem that is exacerbated by the shortage of treatment options for ...

Myqorzo (aficamten) is a new therapy for oHCM, improving functional capacity and symptoms, with an annual cost of $108,400. The Myqorzo & You program provides personalized support, including insurance ...

Software developers have spent the past two years watching AI coding tools evolve from advanced autocomplete into something that can, in some cases, build entire applications from a text prompt. Tools ...

The funding comes from the Personalized Regenerative Immunocompetent Nanotechnology Tissue (PRINT) program at ARPA-H, an agency within the U.S. Department of Health and Human Services. The PRINT ...

Orphan Drug Designation applies to approximately 50,000 Patients who predominantly suffer from severe chronic pain due ...

Renewable Natural Gas (RNG) 45Z Tax Credit Revenue -- Current guidance implies an annual run rate of $30 million, pending final regulatory guidance.

SomaTX Design Inc. is the maker of KneeMo®, a smart wearable device designed to reduce knee pain and improve quadriceps ...